Bruceoside A

Bruceoside A
Product Name Bruceoside A
CAS No.: 63306-30-9
Catalog No.: CFN95080
Molecular Formula: C32H42O16
Molecular Weight: 682.7 g/mol
Purity: >=98%
Type of Compound: Diterpenoids
Physical Desc.: Powder
Targets: RNA synthesis
Source: The seeds of Brucea javanica.
Solvent: DMSO, Pyridine, Methanol, Ethanol, etc.
Price: $318/10mg
Bruceoside A could be transformed into the potent anticancer component brusatol in vivo, rather than its direct deglycosylated metabolite bruceosin. It significantly inhibited P-388 lymphocytic leukemic cell RNA and protein synthesis in tissue culture.
Inquire / Order:
Technical Inquiries:
Tel: +86-27-84237783
Fax: +86-27-84254680

1 Building, No. 83, CheCheng Rd., Wuhan Economic and Technological Development Zone, Wuhan, Hubei 430056, PRC
Providing storage is as stated on the product vial and the vial is kept tightly sealed, the product can be stored for up to 24 months(2-8C).

Wherever possible, you should prepare and use solutions on the same day. However, if you need to make up stock solutions in advance, we recommend that you store the solution as aliquots in tightly sealed vials at -20C. Generally, these will be useable for up to two weeks. Before use, and prior to opening the vial we recommend that you allow your product to equilibrate to room temperature for at least 1 hour.

Need more advice on solubility, usage and handling? Please email to:

The packaging of the product may have turned upside down during transportation, resulting in the natural compounds adhering to the neck or cap of the vial. take the vial out of its packaging and gently shake to let the compounds fall to the bottom of the vial. for liquid products, centrifuge at 200-500 RPM to gather the liquid at the bottom of the vial. try to avoid loss or contamination during handling.
  • Biochem Biophys Res Commun.2017, 482(4):1095-1101
  • J of the Korean Society of Cosmetics and Cosmetology2018, 399-406
  • Current Traditional Medicine, 2021, 7:326-335(10).
  • Chemistr of plant2016, 2016021195
  • Genes (Basel).2021, 12(7):1024.
  • Molecules.2017, 22(12)
  • J of Ana. Chem.2019, 74(11):1113-1121
  • Phytochemistry.2021, 181:112539.
  • J Ethnopharmacol.2022, 291:115159.
  • Front Pharmacol.2021, 12:690113.
  • Dehydrobruceantinol

    Catalog No: CFN89342
    CAS No: 99132-99-7
    Price: Inquiry(
    Bruceantinoside A

    Catalog No: CFN89343
    CAS No: 79439-85-3
    Price: Inquiry(
    Yadanzioside F

    Catalog No: CFN96423
    CAS No: 95258-11-0
    Price: Inquiry(
    Bruceoside A

    Catalog No: CFN95080
    CAS No: 63306-30-9
    Price: $318/10mg
    Yadanzioside A

    Catalog No: CFN96425
    CAS No: 95258-15-4
    Price: Inquiry(
    Yadanzioside C

    Catalog No: CFN96424
    CAS No: 95258-16-5
    Price: Inquiry(
    Yadanzioside G

    Catalog No: CFN96422
    CAS No: 95258-17-6
    Price: $413/5mg

    Catalog No: CFN89337
    CAS No: 53662-98-9
    Price: Inquiry(
    Yadanzioside M

    Catalog No: CFN96418
    CAS No: 101559-99-3
    Price: Inquiry(
    Picrasinol B

    Catalog No: CFN97461
    CAS No: 89498-91-9
    Price: Inquiry(
    J Pharm Sci. 1979 Jul;68(7):883-7.
    Antitumor agents. XXXIV: Mechanism of action of bruceoside A and brusatol on nucleic acid metabolism of P-388 lymphocytic leukemia cells.[Pubmed: 458610 ]
    The quassinoids bruceantin, brucein D, brucein E, Bruceoside A, and brusatol significantly inhibited P-388 lymphocytic leukemic cell RNA and protein synthesis in tissue culture. However, DNA synthesis inhibition seemed to correlate more directly with the anti-neoplastic activity of these compounds in the in vivo P-338 survival system.
    In vitro, brusatol and Bruceoside A marginally inhibited 10-day P-388 lymphocytic leukemia DNA polymerase, RNA polymerase, thymidylate synthetase, dihydrofolate reductase, phosphoribosyl pyrophosphate aminotransferase, and cathepsin protease activities. In vivo studies demonstrated similar inhibition and elevated cyclic AMP levels, correlating positively with the antineoplastic activity of individual compounds. Purine synthesis was inhibited drastically by brusatol in vivo, and one key inhibition site in purine synthesis was at phosphoribosyl pyrophosphate aminotransferase, the regulatory enzyme.
    Histone phosphorylation and ribonucleotide reductase activity also were inhibited marginally by brusatol.
    J Pharm Biomed Anal. 2019 Jun 5;170:264-272.
    Pharmacokinetic study on bruceoside A revealed the potential role of quassinoid glycosides for the anticancer properties of Fructus Bruceae.[Pubmed: 30947127 ]
    Bruceoside A, an abundant quassinoid glycoside in Fructus Bruceae, was chosen for the pharmacokinetic study. It is the first case report on the pharmacokinetic study of quassinoid glycosides so far.
    A sensitive, accurate, and repeatable UHPLC-MS/MS method was developed for the determination of Bruceoside A and its major metabolite. The results showed Bruceoside A could be transformed into the potent anticancer component brusatol in vivo, rather than its direct deglycosylated metabolite bruceosin. And the intestinal bacteria were proposed to take a potential role during such transformation.
    Based on the present study, it could be concluded that the quassinoid glycosides possessing weak activities in vitro could do contribution to the anticancer properties of Fructus Bruceae in vivo via transforming into more active metabolites.
    Planta Med. 2002 Aug;68(8):730-3.
    Bioactive constituents of the seeds of Brucea javanica.[Pubmed: 12221597 ]

    A new quassinoid, yadanziolide S (1), was isolated from the seeds of the traditional Chinese medicinal herb, Brucea javanica, along with ten known compounds, flazin, bruceine D, yadanziolide B, Bruceoside A, yadanziolide S, yadanzigan, glycerol 1,3-bisoleate, azelaic acid, (+/-)-8-hydroxyhexadecanoic acid, and vanillin.
    Compound 1 is the first quassinoid to have been isolated from B. javanica without a methyleneoxy bridge between C-8 and C-13, and its structure was determined using spectroscopic methods, and confirmed by single-crystal X-ray diffraction. All isolates were evaluated for their potential to induce human promyelocytic leukemia (HL-60) cell differentiation, and to inhibit cyclooxygenase-1 (COX-1), -2 (COX-2), and 7,12-dimethylbenz[a]anthracene (DMBA)-induced lesions in a mouse mammary organ culture model.

    Catalog No: CFN95021
    CAS No: 1178-24-1
    Price: $268/10mg
    Buddlenoid A

    Catalog No: CFN95025
    CAS No: 142750-32-1
    Price: $368/5mg
    Columbianetin beta-D-glucopyranoside

    Catalog No: CFN95038
    CAS No: 55836-35-6
    Price: $288/5mg
    Cistantubuloside C1

    Catalog No: CFN95121
    CAS No: 620632-36-2
    Price: $298/10mg
    Arisantetralone B

    Catalog No: CFN95211
    CAS No: 1161947-96-1
    Price: $413/5mg
    Polygalacin D2

    Catalog No: CFN95241
    CAS No: 66663-92-1
    Price: $413/5mg
    Cannabisin A

    Catalog No: CFN95287
    CAS No: 130508-46-2
    Price: $318/5mg
    Glaucoside A

    Catalog No: CFN95299
    CAS No: 81474-91-1
    Price: $318/5mg
    Euphorbia factor L25

    Catalog No: CFN95339
    CAS No: 303174-98-3
    Price: $368/5mg

    Catalog No: CFN95376
    CAS No: 74064-17-8
    Price: $318/10mg